Urine-derived stem cell therapy shows promise for reducing surgery complications in boys with hypospadias
NCT ID NCT07495176
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether stem cell exosomes from a boy's own urine could improve healing after surgery for hypospadias, a common birth defect where the urethra opening is not at the tip of the penis. 82 boys with severe hypospadias were split into two groups: one received standard surgery plus the exosome treatment, the other had surgery alone. The goal was to see if the exosomes help rebuild the missing spongy tissue and lower the risk of complications like fistulas or narrowing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOSPADIAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Children's Hospital
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Blood-Derived patch reduce complications in penile surgery?
- Reading the genetic code to understand differences in sex development
- Numbing injection may increase complication risk in Boys' genital surgery
- Which nerve block works best for kids' post-surgery pain?
- New pain block study aims to ease Kids' surgery recovery
- New study seeks best pain relief for kids after hypospadias surgery